Commercialisation
Assessment of pharmaceutical products for potential commercialisation.
Partnering with Avallon.
Information for organisations considering product, licensing, supply or portfolio opportunities.
Working together
Structured conversations about the right opportunities.
Avallon considers opportunities that may strengthen responsible medicine access and sustainable portfolio development.
We welcome enquiries from pharmaceutical organisations, manufacturers, product developers, service providers and supply partners. Every opportunity is subject to appropriate commercial, regulatory, quality and supply evaluation.
Potential partnership areas
Areas open for discussion
Product licensing
In-licensing opportunities that may align with portfolio and healthcare needs.
Portfolio acquisition
Review of established or developing medicine portfolios with relevant potential.
Supply partnerships
Evaluation of quality-led supply arrangements for registered medicines.
Distribution collaboration
Potential engagement with suitable wholesale, pharmacy and healthcare channels.
Lifecycle management
Opportunities involving product maintenance, variations, continuity and market support.
Evaluation considerations
Healthcare needClinical relevanceRegulatory feasibilityProduct qualitySupply reliabilityCommercial sustainabilityPortfolio alignmentLong-term healthcare value
Discuss an opportunity ↗